Stay up to date

Latest News

17th July 2025

UK NSC stakeholder discussion group

On Wednesday 16th July our CEO, Sara Hunt, took part in a small UK National Screening Committee (NSC) stakeholder discussion group.

14th July 2025

Screen4Care project

Screen4Care has launched a recruitment for newborn screening in Ferrara, Italy and in Dijon, France – the conditions include ALD and MLD.

11th July 2025

Newborn screening policy report

Genetic Alliance UK have released a new policy report ‘Time to Decide: Learning from international approaches to newborn screening decision-making’.

6th May 2025

NBS Consultation for MLD

The UK National Screening Committee (UK NSC) has today opened a consultation on evidence relating to newborn screening for metachromatic leukodystrophy (MLD).

23rd April 2025

Our newborn screening campaign for ALD

We are currently working with a team of doctors who are helping to get the evidence together for when newborn screening for ALD is reviewed again by the national screening committee later this year.

23rd March 2025

ISNS European regional meeting 2025

Karen Harrison, our Director of Support, will be attending and presenting at the 13th International Society for Neonatal Screening (ISNS) European regional meeting in Luxembourg.

18th February 2025

Newborn screening for ALD – The Generation Study and our campaign

Adrenoleukodystrophy (ALD) and Metachromatic Leukodystrophy (MLD) are conditions being included in The Generation Study. We hope the study will demonstrate the importance of screening for conditions at birth and results could support our newborn screening campaign for ALD.

22nd January 2025

The Generation Study update

Update from The Generation Study to share latest figures. It has been given approval by the Department of Health and Social Care to continue the study until March 2027.